abrdn plc boosted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 61.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 157,293 shares of the company's stock after acquiring an additional 59,824 shares during the period. abrdn plc owned 0.17% of Acadia Healthcare worth $6,237,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. grew its stake in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after acquiring an additional 345 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Fifth Third Bancorp lifted its holdings in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after purchasing an additional 454 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares in the last quarter.
Acadia Healthcare Trading Down 1.7 %
ACHC traded down $0.70 on Wednesday, reaching $41.28. 1,051,753 shares of the company's stock were exchanged, compared to its average volume of 1,517,605. The company's 50 day moving average is $42.10 and its 200-day moving average is $54.42. The company has a market cap of $3.83 billion, a price-to-earnings ratio of 13.53, a PEG ratio of 1.75 and a beta of 1.30. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
Analyst Ratings Changes
ACHC has been the topic of a number of recent research reports. Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a report on Friday, November 22nd. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Cantor Fitzgerald restated a "neutral" rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.
Read Our Latest Report on Acadia Healthcare
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
